



Bekungekho mahluko ubalulekileyo kwi-serum lutein concentrations kunye namanqanaba eMPOD kwisiseko phakathi kwamaqela. Ukunyuka kwe-serum lutein concentration kunye namanqanaba e-MPOD kwiinyanga ezi-3 ngokulandelelanayo, i-89% kunye ne-38% kwiqela le-lutein yamahhala kunye ne-97% kunye ne-17% kwiqela le-lutein esters. I-serum lutein concentrations kumaqela omabini kunye namanqanaba e-MPOD kwiqela le-lutein yamahhala anyuke kakhulu (p

Siphande impembelelo ye-antihypertensive ye-lutein kwi-NG-nitro-L-arginine methyl ester hydrochloride (L-NAME) -i-rats ye-hypertensive. I-MAP kumaqela e-lutein yayixhomekeke kwithamo-ngaphantsi kunaleyo ikwiqela le-L-NAME. I-Lutein (2 mg / kg) ithintele kakhulu izinga lentliziyo elincitshisiweyo elibangelwa ngu-L-NAME. Ezi ziphumo zibonisa ukuba i-lutein inika i-antihypertensive kunye ne-antioxidant iziphumo ezichasene ne-LNAME-induced hypertension kwiimpuku.


Ukutya kwe-lutein ye-0.72 (iqela le-lutein eliphakathi) kunye ne-1.44 mg / mL (iqela le-high-lutein yesiselo) kunciphisa ukukhathala okubonakalayo, iimpawu ze-turbidity eziphuculweyo ze-crystalline lens, ukunciphisa i-hepatic concentration ye-MDA, ukunyuka kwe-GSH ye-hepatic, kunye nokwandisa kakhulu imisebenzi ye-GSH, i-GSH, i-GrPPAT, i-antioxidant ye-hepatic iimpuku. Ezi datha zibonisa ukuba isiselo esityebileyo se-lutein siyindlela esebenzayo nengenabungozi yokunyusa umthamo opheleleyo wokuchasana ne-oxidation yeelensi kunye nokunciphisa ukudinwa okubonakalayo.

Umonakalo we-photooxidative okhanyayo ohlaza okwesibhakabhaka uye wabandakanyeka kwi-etiology ye-age-related macular degeneration (AMD). I-macular pigment xanthophylls lutein (L) kunye ne-zeaxanthin (Z) kunye ne-n-3 fatty acids zinokuwunciphisa lo monakalo kwaye zehlise umngcipheko we-AMD. Ukukhuselwa kwe-Foveal kwakungekho kwizilwanyana ezingenayo i-xanthophyll kodwa kwabonakala emva kokuxhaswa. Emva kwexesha elide lokunqongophala kwe-xanthophyll, i-lutein okanye i-zeaxanthin supplementation ikhusele i-fovea kumonakalo obangelwa kukukhanya okuluhlaza.







